LDL tagged posts

The liver’s job of clearing harmful substances from the body is so essential that the organ may have implications for addressing unexpected diseases, including Alzheimer’s and heart disease. A promising example comes from new Keck School of Medicine of USC research published in the Journal of Biological Chemistry.

The study, conducted in aged rats, shows that an experimental drug called cinaciguat reverses effects of aging in the liver. This, in turn, may lower the risk of Alzheimer’s disease and clogged arteries...

A common gut bacterium produces a molecule that slows cholesterol production in the liver. When researchers gave the molecule to mice prone to artery disease, the animals developed roughly half as much fatty plaque as untreated controls.

The molecule acts on the same enzyme targeted by statins, the widely used cholesterol-lowering drugs. That connection offers a concrete explanation for something harder to untangle: how bacteria living in the intestine might influence the health of arteries elsewhere in the body.

Researchers at institutions including Sun Yat-sen University and Shenzhen ...

People looking to reduce their cholesterol and trim fat from around their waist could try swapping meat for Quorn protein, according to the findings from a new study by Northumbria University, Newcastle, published in the European Journal of Nutrition, which saw positive effects in both areas in just two weeks.

Researchers from the University found that participants who ate Quorn products — the popular mycoprotein-based meat substitute — over just a two-week period, saw a significant 12% drop in ‘bad’ LDL cholesterol and a 7% fall in total cholesterol, compared to those who ate similar products made from red and processed meat. In addition, they also reduced their waist circumference by close to 1cm (0.95cm) on average over the 14 days.

Such a drop in total cholesterol levels cou...

Increased levels of lipoprotein(a), a variant of “bad cholesterol” in the bloodstream, are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results of a new study which tracked the issue over the course of 16 years.

The results, published today in Current Medical Research & Opinion, suggest that current cholesterol-lowering medications may not be effective at reducing the risk of recurrent CHD—such as a heart attack—due to elevated Lp(a).

“This finding adds to growing evidence of a relationship between increased Lp(a) and the risk of recurrent CHD,” says lead author Associate Professor Leon Simons, from the School of Clinical Medicine, at the Universi...